Roche Holding AG (RO.SW) stock analysis

In our weekly check, Roche Holding AG is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 2.

About Roche Holding AG

Roche Holding AG is a Healthcare company (Drug Manufacturers - General) based in Switzerland, listed on SIX as RO.SW.

What our checks show for RO.SW

Red flags

• Revenue fell 0.9% a year over the last 3 years.
• Thinly traded (about 28 thousand shares a day): buying and selling can move the price.

Warning signs

• The net margin fell by 1.2 points over 5 years, to 20.9%: the company keeps less of each sale as profit.
• Analysts expect only about 4.2% a year of growth in revenue.
• The stock has fallen as much as 54% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 2.5 years.

Strengths

• Operating profit covers interest 14.7 times over.
• The gross margin is 72.9% and has risen by 4.3 points: pricing power is holding.
• Operating cash flow is 1.38x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 14.5% a year over the next years.
• Analysts expect the net margin to improve by 6.6 points from today's 20.9%.
• The company keeps 20.9% of its revenue as net profit.

Similar companies

AZN · NVS · AMGN · MRK · GILD · NVO

Questions

What grade does Roche Holding AG (RO.SW) have?

In our weekly check, Roche Holding AG is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of RO.SW stock?

This week's biggest flags for Roche Holding AG: Weak revenue growth, Thinly traded, Margins falling. In total 6 of 25 checks show a warning or a red flag.

What does Roche Holding AG do?

Roche Holding AG is a Healthcare company (Drug Manufacturers - General) based in Switzerland, listed on SIX as RO.SW.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis